Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Atrium Therapeutics, Inc. (RNA) had Current Liabilities of 195.45M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
0.86M |
|
-237.10M |
|
-- |
|
0.86M |
|
88.74M |
|
-87.88M |
|
17.38M |
|
-237.10M |
|
-237.10M |
|
-237.10M |
|
-237.10M |
|
-237.10M |
|
-237.10M |
|
-87.88M |
|
-87.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
1.80B |
|
35.11M |
|
35.11M |
|
1.96B |
|
|
Current Liabilities |
195.45M |
-- |
|
-- |
|
269.45M |
|
-1.58B |
|
1.69B |
|
1.69B |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-10218.84% |
|
-10218.84% |
|
-- |
|
-27569.88% |
|
-27569.88% |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
15.03% |
|
-14.04% |
|
-12.11% |
|
-14.04% |
|
-- |
|
-- |
|
-- |
|